RxDoctor Payments Data

Paul Menard-Katcher, MD

Internal Medicine · Aurora, CONPI 1104980291

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,106 of the $31,922 with a category attached, or 97.4%. Evoendo, Inc accounts for 97.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $31,173 and has fallen 99.3% since, to $208 in 2025. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,922in general payments, 2019–2025

Across 13 payments — averaging $2455.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evoendo, Inc$31K
  • Olympus America Inc.$311
  • Regeneron Healthcare Solutions, Inc.$183
  • Boston Scientific$127
  • Conmed Corporation$107
  • Medtronic$88
$172,587in research payments, 2019–2025

Across 54 payments — averaging $3196.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$154K
  • Ironwood Pharmaceuticals, Inc$19K

What the payments were for

  • Consulting fees$31,10697%
  • Food & beverage$8153%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,922 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$63,808
Medicare patients
307
Services billed
578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin13$29,555
MotegrityPrucalopride Succinate11$14,946
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates51$3,311
Omeprazole53$1,723
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl74$1,249
Bethanechol Chloride14$818
Pantoprazole Sodium27$405
Fluconazole15$295
Famotidine26$251

Paid to pharmacies, not to this prescriber.

Other internal medicine in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →